Ombretta Melaiu

1.9k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Ombretta Melaiu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Ombretta Melaiu has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Immunology. Recurrent topics in Ombretta Melaiu's work include Occupational and environmental lung diseases (14 papers), Immune Cell Function and Interaction (11 papers) and Neuroblastoma Research and Treatments (8 papers). Ombretta Melaiu is often cited by papers focused on Occupational and environmental lung diseases (14 papers), Immune Cell Function and Interaction (11 papers) and Neuroblastoma Research and Treatments (8 papers). Ombretta Melaiu collaborates with scholars based in Italy, United Kingdom and United States. Ombretta Melaiu's co-authors include Doriana Fruci, Valeria Lucarini, Loredana Cifaldi, Federica Gemignani, Franco Locatelli, Aurora Castellano, Stefano Landi, Renata Boldrini, Giuseppe Jurman and Cesare Furlanello and has published in prestigious journals such as Nature Communications, PLoS ONE and Oncogene.

In The Last Decade

Ombretta Melaiu

39 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

2020 312 citations Ombretta Melaiu, Valeria Lucarini et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Ombretta Melaiu

Since Specialization

Citations

This map shows the geographic impact of Ombretta Melaiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ombretta Melaiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ombretta Melaiu more than expected).

Fields of papers citing papers by Ombretta Melaiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ombretta Melaiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ombretta Melaiu. The network helps show where Ombretta Melaiu may publish in the future.

Co-authorship network of co-authors of Ombretta Melaiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ombretta Melaiu. A scholar is included among the top collaborators of Ombretta Melaiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ombretta Melaiu. Ombretta Melaiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 2025 ·Cancers ·Silvia Pomella, (unknown), Matteo Cassandri, (unknown), Ombretta Melaiu, Francesco Marampon, Rossella Rota, Giovanni Barillari	0
2	The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy 2025 ·Pharmacology & Therapeutics ·(unknown), Gianfranco Di Giuseppe, (unknown), (unknown), Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta	0
3	Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 2025 ·Journal of Experimental & Clinical Cancer Research ·(unknown), (unknown), Ombretta Melaiu, (unknown), Stefan Ebert, Nicola Tumino, Elisabetta Vulpis, (unknown), (unknown), Manuela Antonioli, (unknown), Simona Caruso, Marco Scarsella, Cristiano De Stefanis, Veronica Marabitti, Silvia Campello, Doriana Fruci, Paola Vacca, Ignazio Caruana, Francesca Nazio	0
4	NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 2024 ·Immunology Letters ·Marco Greppi, (unknown), Valentina Obino, (unknown), (unknown), Davide Frumento, (unknown), (unknown), Ombretta Melaiu, (unknown), Simona Candiani, Valerio Gaetano Vellone, Federica Papaccio, Silvia Pesce, Emanuela Marcenaro	12
5	Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 2024 ·International Journal of Molecular Sciences ·Silvia Pomella, Ombretta Melaiu, Loredana Cifaldi, Roberto Bei, M Gargari, Vincenzo Campanella, Giovanni Barillari	4
6	DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 2023 ·Frontiers in Immunology ·Loredana Cifaldi, Ombretta Melaiu, Roberto Giovannoni, Monica Benvenuto, Chiara Focaccetti, (unknown), Giovanni Barillari, Roberto Bei	17
7	Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 2022 ·Journal of Experimental & Clinical Cancer Research ·Valeria Lucarini, Ombretta Melaiu, Silvia D’Amico, Fabio Pastorino, (unknown), Marco Scarsella, Marco Pezzullo, Adele De Ninno, Valentina Doria, Michele Cilli, Laura Emionite, Paola Infante, Lucia Di Marcotullio, Maria Antonietta De Ioris, Giovanni Barillari, Rita Alaggio, Luca Businaro, Mirco Ponzoni, Franco Locatelli, Doriana Fruci	17
8	EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma 2020 ·International Journal of Molecular Sciences ·(unknown), Marcella Barbarino, Elisa Barone, Antonio Giordano, Luca Luzzi, (unknown), (unknown), (unknown), (unknown), Ombretta Melaiu, (unknown), Monica Cipollini, (unknown), Alda Corrado, Federica Gemignani, Stefano Landi	11
9	Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 2020 ·Cancer Immunology Research ·(unknown), Paola Infante, Elisa Ferretti, Ombretta Melaiu, Cecilia Battistelli, Valeria Lucarini, Mirco Compagnone, Carmine Nicoletti, Aurora Castellano, Stefania Petrini, Marzia Ognibene, Annalisa Pezzolo, Lucia Di Marcotullio, Roberto Bei, Lorenzo Moretta, Vito Pistoia, Doriana Fruci, Vincenzo Barnaba, Franco Locatelli, Loredana Cifaldi	34
10	Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma 2020 ·Thyroid ·Federica Gemignani, Cristina Romei, Raffaele Ciampi, Alda Corrado, Ombretta Melaiu, Gisella Figlioli, Alessandra Bonotti, Rudy Foddis, Alfonso Cristaudo, Giovanni Pellegrini, A Vivaldi, Monica Cipollini, Stefano Landi, Rossella Elisei	5
11	Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 2019 ·Fertility and Sterility ·Monica Cipollini, Stefano Luisi, Paola Piomboni, Alice Luddi, Debora Landi, Ombretta Melaiu, Gisella Figlioli, Sonia Garritano, Valentina Cappelli, Paola Viganò, Federica Gemignani, Felice Petraglia, Stefano Landi	6
12	Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 2018 ·OncoImmunology ·Renata Boldrini, Maria Debora De Pasquale, Ombretta Melaiu, Marco Chierici, Giuseppe Jurman, (unknown), Nunzio Salfi, Aurora Castellano, Paola Collini, Cesare Furlanello, Vito Pistoia, Loredana Cifaldi, Monica Terenziani, Doriana Fruci	26
13	PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 2017 ·Clinical Cancer Research ·Ombretta Melaiu, Marco Mina, Marco Chierici, Renata Boldrini, Giuseppe Jurman, Paolo Romania, Valerio D’Alicandro, (unknown), Aurora Castellano, Tao Liu, Cesare Furlanello, Franco Locatelli, Doriana Fruci	93
14	MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 2017 ·OncoImmunology ·(unknown), (unknown), Ombretta Melaiu, Annalisa Pezzolo, Aurora Castellano, Renata Boldrini, Elisa Ferretti, Doriana Fruci, Lorenzo Moretta, Vito Pistoia, Franco Locatelli, Loredana Cifaldi	39
15	Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 2017 ·Occupational and Environmental Medicine ·Chiara De Santi, (unknown), Alessandra Bonotti, Ombretta Melaiu, Monica Cipollini, (unknown), Veronika Vymetálková, Elisa Barone, Elisa Paolicchi, Alda Corrado, (unknown), (unknown), (unknown), Pavel Vodička, Luciano Mutti, Rudy Foddis, Alfonso Cristaudo, Federica Gemignani, Stefano Landi	7
16	A Comprehensive Meta-analysis of Case–Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Gisella Figlioli, Rossella Elisei, Cristina Romei, Ombretta Melaiu, Monica Cipollini, Franco Bambi, Bowang Chen, (unknown), Alfonso Cristaudo, Kari Hemminki, Federica Gemignani, Asta Försti, Stefano Landi	17
17	Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 2016 ·Archives of Toxicology ·(unknown), Monica Cipollini, Roman Tremmel, Cristina Romei, Gisella Figlioli, Federica Gemignani, Ombretta Melaiu, Chiara De Santi, Elisa Barone, Rossella Elisei, Eric Seiser, Federico Innocenti, Ulrich M. Zanger, Stefano Landi	5
18	A Common Polymorphism Within MSLN Affects miR-611 Binding Site and Soluble Mesothelin Levels in Healthy People 2014 ·Journal of Thoracic Oncology ·Sonia Garritano, Chiara De Santi, (unknown), Ombretta Melaiu, Monica Cipollini, Elisa Barone, Marco Lucchi, Roberto Barale, Luciano Mutti, Federica Gemignani, Alessandra Bonotti, Rudy Foddis, Alfonso Cristaudo, Stefano Landi	20
19	Expression status of candidate genes in mesothelioma tissues and cell lines 2014 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Ombretta Melaiu, Erika Melissari, Luciano Mutti, (unknown), Chiara De Santi, Caterina Iofrida, (unknown), Alfonso Cristaudo, Alessandra Bonotti, Monica Cipollini, (unknown), Rudy Foddis, Marco Lucchi, Silvia Pellegrini, Federica Gemignani, Stefano Landi	30
20	The regulatory roles of phosphatases in cancer 2013 ·Oncogene ·Justin Stebbing, (unknown), (unknown), R. Siobhan Darrington, Ombretta Melaiu, (unknown), Georgios Giamas	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact